PATEL DINESH V PH D Insider Trading Activity

Average Profitability
243.28%
Insider Buys Quantity
1
Insider Buys Sum
$337,000.00
Insider Sells Quantity
14
Insider Sells Sum
$10.96M

Insider Activity of PATEL DINESH V PH D

According to the SEC Form 4 filings, PATEL DINESH V PH D, being in a position of

  1. President and CEO at Protagonist Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 437352 shares for $53.06M,
    over all time since 2017-12-20, has bought 60000 shares for $337,000, and sold 868184 shares for $67.48M.

Biography of PATEL DINESH V PH D

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $53,063,29711100

Comparison of Insiders on Amount of Buys and Sells

2026-09-10SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
7,278
0.0112%
$144.10$1.05M-3.03%
2026-09-09SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
63,548
0.0996%
$146.18$9.29M-2.89%
2026-09-08SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
54,174
0.0821%
$145.87$7.9M-3.45%
2026-08-11SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
34,239
0.0533%
$148.52$5.09M-3.1%
2026-08-10SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
65,761
0.0991%
$149.11$9.81M-4.19%
2026-05-12SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
75,000
0.1168%
$100.12$7.51M+38.38%
2026-03-25SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
54,641
0.0829%
$101.00$5.52M+28.8%
2026-01-27SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
4,068
0.0065%
$83.19$338,417+34.75%
2026-01-26SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
24,890
0.0407%
$84.03$2.09M+35.41%
2026-01-23SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
19,315
0.0315%
$84.59$1.63M+33.62%
2026-01-20SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
34,438
0.0545%
$82.48$2.84M+31.61%
2025-07-25SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
10,415
0.0167%
$54.78$570,534+58.15%
2025-07-23SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
17,520
0.0286%
$54.79$959,921+60.73%
2025-07-22SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
22,065
0.0356%
$55.05$1.21M+58.21%
2025-07-21SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
12,859
0.0206%
$54.86$705,445+56.81%
2025-02-19SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
5,359
0.0091%
$38.18$204,607+47.21%
2024-11-26SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
21,480
0.0373%
$46.25$993,450+16.91%
2024-11-25SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
78,520
0.1349%
$46.96$3.69M+14.01%
2024-06-07SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
35,000
0.0603%
$35.19$1.23M+19.77%
2024-04-01SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
25,000
0.0429%
$28.31$707,750+36.74%
Total: 30
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.